Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04972526 · ClinicalTrials.gov registry record
Resuscitative TEE Collaborative Registry
A clinical trial of Cardiac Arrest and Shock, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT04972526: Recruiting study of Cardiac Arrest and Shock, sponsored by University of Pennsylvania.
NCT04972526 is a study of Cardiac Arrest and Shock that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 1,000 participants, below the 1,448-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04972526, a study of Cardiac Arrest and Shock, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The general objective of this study is to evaluate the clinical impact and safety of focused, point-of-care transesophageal echocardiography (TEE) used during the evaluation of critically-ill patients in the emergency and intensive care settings. The target population for this study are critically-ill patients over the age of 18 who as part of their routine clinical care are receiving a focused TEE. The primary objective of this study is to determine the clinical impact and safety of TEE performed during the evaluation of critically-ill patients in the emergency department and intensive care settings. The secondary objective(s) of this study are to characterize the use of this imaging modality in the subsets of critically-ill patients in shock and cardiac arrest; including but not limited to; description of the frequency of studies, clinical indications, clinician characteristics, echocardiography findings, timing of studies, procedure-related complications and patient outcomes.
Primary Outcome
Determination of ROSC and survival to hospital discharge
Conditions Studied
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2027-12-15 |
What NCT04972526 shows while recruiting
NCT04972526 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 1,448-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (31% lower).
The record links to 5 conditions, with Cardiac Arrest appearing as the primary indexed condition, and to 0 interventions.
NCT04972526 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04972526 about?
NCT04972526 is a clinical study titled "Resuscitative TEE Collaborative Registry". The general objective of this study is to evaluate the clinical impact and safety of focused, point-of-care transesophageal echocardiography (TEE) used during the evaluation of critically-ill patients in the emergency and intensive care settings. The target population for this study are critically-i...
What is the current status of trial NCT04972526?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2020-12-01. Estimated completion is 2027-12-15.
What conditions does trial NCT04972526 study?
This clinical trial studies the following conditions: Cardiac Arrest, Shock, Cardiac Arrest, Out-Of-Hospital, Hemodynamic Instability, Cardiac Arrest Circulatory.
Who is sponsoring clinical trial NCT04972526?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04972526 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Arrest
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04972526's enrollment target sits among peer trials
1,000 5th of 31 higher than 27 of 31 other Cardiac Arrest trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Arrest trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Amiodarone in Shockable Cardiac Arrest
RECRUITING · Phase 3
-
Hospital Airway Resuscitation Trial
RECRUITING · NA
-
Post-CA Neuroprotection With Magnesium
RECRUITING · Phase 1
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Hydrogen's Feasibility and Safety as a Therapy in ECPR
RECRUITING · Phase 1
-
Quality of Pediatric Resuscitation in a Multicenter Collaborative
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI